Lieff Cabraser Heimann & Bernstein, LLP - Ortho Evra Side Effects Lawsuit
Home
About Our Firm
Our Attorneys
Contact Us
 
   
   
  Women who use the Ortho Evra birth control patch are at risk to suffer from life-threatening blood clots and strokes.  
   
  Our law firm is representing women across America with Ortho Evra injuries.  
   
  Ortho Evra is a trademark of Ortho-McNeil Pharma-
ceuticals Inc. and is used for product identification purposes only.
 


 

September 20, 2006 FDA- MedWatch - Ortho Evra (norelgestromin | ethinyl estradiol)

MedWatch - The FDA Safety Information and Adverse Event Reporting Program
Ortho and FDA notified healthcare professionals and patients about revision to the prescribing information to inform them of the results of two separate epidemiology studies that evaluated the risk of developing a serious blood clot in women using Ortho Evra compared to women using a different oral contraceptive. The first study found that the risk of non-fatal venous thromboembolism (VTE) associated with the use of Ortho Evra contraceptive patch is similar to the risk associated with the use of oral contraceptive pills containing 35 micrograms of ethinyl estradiol and norgestimate. The second study found an approximate 2-fold increase in the risk of medically verified VTE events in users of Ortho Evra compared to users of norgestimate- containing oral contraceptives containing 35 micrograms of estrogen. Although the results of the two studies differ, the results of the second study support FDA's concerns regarding the potential for Ortho Evra use to increase the risk of blood clots in some women.
Prescribing information for Ortho Evra continues to recommend that women with concerns or risk factors for thromboemboli disease talk with their healthcare professionals about using Ortho Evra versus other contraceptive options.
Read the complete MedWatch 2006 Safety summary, including links to the Sponsor's updated prescribing information and the FDA's Q&As regarding this issue.
About Lieff Cabraser
Founded in 1972, Lieff Cabraser Heimann & Bernstein, LLP is an over sixty attorney law firm with offices in San Francisco, New York and Nashville. For the last five years, the National Law Journal recognized Lieff Cabraser as one of the top plaintiffs’ law firms in America.
Contact a Personal Injury Attorney
For our personal injury cases, we bring a team of experienced lawyers. Each client is assigned an individual lawyer. In addition, we have on staff multiple nurses, legal assistants, scientific analysts and case clerks to assist the attorneys. To contact a personal injury attorney at Lieff Cabraser, click here. To learn more about our firm, click here.
Additional Lieff Cabraser Information: Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York and Nashville, is one of the largest law firms in the United States that represents only plaintiffs. We have been nationally recognized for our representation of victims of dangerous and defective medical products. We are representing Ortho Evra birth control patch patients in individual peronal injury lawsuits.
Our clients come from across America, including the states of Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and Wyoming. Learn more about our firm.
Disclaimer: The hiring of legal professionals is an important decision that should not be based on advertising alone. Please read our attorney advertising disclaimer.
Trademark Notice: Ortho Evra is a trademark of Ortho-McNeil Pharmaceuticals Inc. and is used for product identification purposes only. The law firm of Lieff Cabraser Heimann & Bernstein, LLP, is in no way affiliated with Ortho-McNeil Pharmaceuticals Inc. or its subsidiary, Ortho Women's Health.
Copyright © 2007 Lieff Cabraser Heimann & Bernstein, LLP